How Denmark Became Europe’s Medical Cannabis Pioneer

Despite a global increase in support for the use of medical marijuana, patients across Europe have been left frustrated by the reluctance of governments to make cannabis products available to those who stand to benefit from them. France, for example, is still in the early stages of exploring medicinal cannabis, while official guidelines in the UK have made it extremely difficult for clinicians to prescribe cannabis products, and patients to access them. Fortunately, however, Denmark looks set to break the mould, having launched a unique medical cannabis pilot programme in 2018. Due to run for a period of four years, the programme has recently passed its halfway point, and the results of the initiative are expected to inform future legislation on the use of medicinal cannabis in the country. Related Post France – The Latest in Cannabis What Does The Programme Entail? A limited number of medical cannabis products, such as Sativex and Nabilone, have been available on prescription in Denmark for specific conditions since 2011. However, given that these medications are only approved to treat neuropathic pain, doctors have not had the liberty to offer cannabis products to patients suffering from other conditions. For this reason, the government decided to launch a bold new pilot programme that allows doctors to prescribe untested cannabis products for any condition. This means that since January 1st 2018, doctors have effectively been unshackled and given the freedom to use their discretion when deciding which patients should be allowed to try cannabis-based medications. According…

Excerpt only …
READ MORE BELOW
Source : seedman
Link to original : How Denmark Became Europe’s Medical Cannabis Pioneer
reposted by Cannabis News World